Walker's Research Business Information
A publisher of Business Information since 1983  
  
 
Search Business Search Executive   Advanced Search
 
 |  Sign In  |  Hints
Company Name Adolor Corp. Ticker Symbol ADLR

 Address 700 Pennsylvania Dr.
Exton, PA 19341
United States
Email questions@adolor.com Phone 1-484-595-1500
Website www.adolor.com Fax 1-484-595-1520


 
Business Information

The group's principal activity is to discover, develop and market proprietary pharmaceutical products for the treatment of pain and the side effects that are caused by current pain treatments. The group is in the development stage. The group has a portfolio of small molecule product candidates that are in various stages of development ranging from pre-clinical studies to phase i through phase iii clinical trials. Its product candidate, alvimopan, also known as adl 8-2698, is designed to selectively block the effects of narcotic analgesics on the gastrointestinal tract. It has obtained licenses from kwang dong pharmaceutical co ltd and santen pharmaceutical co ltd of Japan to develop and market dermal formulations of adl 2-1294 in South Korea and north Korea for dermal pain and ophthalmic pain respectively.

Executive Information
Name Title Email
David MaddenChmn. N/A
James BarrettSr. VP, Chief Scientific Officer, Pres. - Research N/A
Thomas HessVP - Finance, CFO N/A
David JacksonSr. VP, Chief Medical Officer N/A
David StephonVP - Quality Assurance N/A

 
Financial Information  ( All figures in $ '000 )
Year Sales Net Income
2006 15,087(69,738)
2005 15,719(56,797)
2004 25,542(43,586)

 
TO SEE COMPLETE RESULTS SUBSCRIBE NOW TO SEE COMPLETE RESULTS SUBSCRIBE NOW
Click for more Executives

            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory   
 

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.